Alethea Capital Management, LLC reported 36 positions worth $209.32M for the quarter ended Jun 30, 2026, up 67.5% on the prior quarter. It opened 29 new positions, added to 2, trimmed 1 and exited 1. Its largest holding is Axsome Therapeutics, Inc. at 75.9% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| KURA Kura Oncology, Inc. | +638.6K | +41.8% | $7.01M | 11.36% |
| IMRX Immuneering Corp | +450.0K | +1,962.1% | $2.25M | 1.13% |
| VTRS Viatris Inc | +78.4K | – | $1.24M | 0.595% |
| PM Philip Morris International Inc. | +6,834 | – | $1.24M | 0.591% |
| ADP Automatic Data Processing Inc | +5,502 | – | $1.23M | 0.589% |
| WMB Williams Companies, Inc. | +15.3K | – | $1.14M | 0.543% |
| DRI Darden Restaurants Inc | +5,424 | – | $1.12M | 0.534% |
| BMY Bristol Myers Squibb Co | +18.9K | – | $1.09M | 0.52% |
| ED Consolidated Edison Inc | +9,767 | – | $1.08M | 0.516% |
| CVX Chevron Corp | +5,860 | – | $971.35K | 0.464% |
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| VTRS Viatris Inc | +78.4K | $1.24M | 0.595% |
| PM Philip Morris International Inc. | +6,834 | $1.24M | 0.591% |
| ADP Automatic Data Processing Inc | +5,502 | $1.23M | 0.589% |
| WMB Williams Companies, Inc. | +15.3K | $1.14M | 0.543% |
| DRI Darden Restaurants Inc | +5,424 | $1.12M | 0.534% |
| BMY Bristol Myers Squibb Co | +18.9K | $1.09M | 0.52% |
| ED Consolidated Edison Inc | +9,767 | $1.08M | 0.516% |
| CVX Chevron Corp | +5,860 | $971.35K | 0.464% |
| CMCSA Comcast Corp | +38.3K | $939.85K | 0.449% |
| ES Eversource Energy | +12.9K | $933.37K | 0.446% |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| TGB Trekor Metals Ltd | -10.0K | $64.50K | 0.052% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | AXSM Axsome Therapeutics, Inc. | Healthcare | 648.8K | $158.80M | 75.86% | -358 | -0.1% | Reduced | 1.24% |
| 2 | KURA Kura Oncology, Inc. | Healthcare | 2.17M | $23.78M | 11.36% | +638.6K | +41.8% | Added | 2.44% |
| 3 | IMRX Immuneering Corp | Healthcare | 472.9K | $2.36M | 1.13% | +450.0K | +1,962.1% | Added | 0.73% |
| 4 | TEM Tempus AI, Inc. | Healthcare | 31.6K | $1.83M | 0.873% | 0 | 0.0% | Unchanged | 0.02% |
| 5 | VTRS Viatris Inc | Healthcare | 78.4K | $1.24M | 0.595% | +78.4K | – | New | 0.01% |
| 6 | PM Philip Morris International Inc. | Consumer Staples | 6,834 | $1.24M | 0.591% | +6,834 | – | New | 0% |
| 7 | ADP Automatic Data Processing Inc | Technology | 5,502 | $1.23M | 0.589% | +5,502 | – | New | 0% |
| 8 | WMB Williams Companies, Inc. | Energy | 15.3K | $1.14M | 0.543% | +15.3K | – | New | 0% |
| 9 | DRI Darden Restaurants Inc | Consumer Discretionary | 5,424 | $1.12M | 0.534% | +5,424 | – | New | 0% |
| 10 | BMY Bristol Myers Squibb Co | Healthcare | 18.9K | $1.09M | 0.52% | +18.9K | – | New | 0% |
| 11 | ED Consolidated Edison Inc | Utilities | 9,767 | $1.08M | 0.516% | +9,767 | – | New | 0% |
| 12 | CVX Chevron Corp | Energy | 5,860 | $971.35K | 0.464% | +5,860 | – | New | 0% |
| 13 | CMCSA Comcast Corp | Communication Services | 38.3K | $939.85K | 0.449% | +38.3K | – | New | 0% |
| 14 | ES Eversource Energy | Utilities | 12.9K | $933.37K | 0.446% | +12.9K | – | New | 0% |
| 15 | WY Weyerhaeuser Co | Basic Materials | 38.1K | $912.11K | 0.436% | +38.1K | – | New | 0.01% |
Tip. Select a row to see that position’s full history at Alethea Capital Management.
As of its Q2 2026 13F filing, Alethea Capital Management, LLC’s five largest positions were Axsome Therapeutics, Inc. (AXSM) at 75.9%, Kura Oncology, Inc. (KURA) at 11.4%, Immuneering Corp (IMRX) at 1.1%, Tempus AI, Inc. (TEM) at 0.9%, Viatris Inc (VTRS) at 0.6% of the reported portfolio.
Alethea Capital Management, LLC reported a 13F portfolio worth $209.32M across 36 positions for Q2 2026. That is up 67.5% from the previous quarter.
Its largest purchases by value were Kura Oncology, Inc. ($7.01M), Immuneering Corp ($2.25M), Viatris Inc ($1.24M). It opened 29 new positions.
Its largest sales by value were Axsome Therapeutics, Inc. ($87.63K), Trekor Metals Ltd ($64.50K). It exited 1 positions entirely.
From the Form 13F-HR reports Alethea Capital Management, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.